Candriam S.C.A. - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 18 filers reported holding SEATTLE GENETICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$101,187,000
+52.3%
517,099
+32.3%
0.95%
+35.7%
Q2 2020$66,428,000
+56.5%
390,919
+2.9%
0.70%
+49.1%
Q1 2020$42,436,000
-2.2%
379,928
+0.0%
0.47%
+1.1%
Q4 2019$43,408,000
+135.6%
379,904
+76.1%
0.46%
+90.6%
Q3 2019$18,428,000
-7.7%
215,780
-25.5%
0.24%
-2.0%
Q2 2019$19,968,000
-5.0%
289,780
+1.0%
0.25%
-7.4%
Q1 2019$21,011,000
+162.3%
286,869
+102.9%
0.27%
+118.7%
Q4 2018$8,010,000
-24.3%
141,374
+3.0%
0.12%
-12.8%
Q3 2018$10,581,000
+36.7%
137,200
+17.7%
0.14%
+15.6%
Q2 2018$7,741,000
+32.1%
116,600
+4.1%
0.12%
+22.0%
Q1 2018$5,862,000
-2.2%
112,0000.0%0.10%
-3.8%
Q4 2017$5,992,000
+379.0%
112,000
+387.0%
0.10%
+372.7%
Q3 2017$1,251,000
-84.7%
23,000
-85.5%
0.02%
-85.7%
Q2 2017$8,201,000
+31.1%
158,500
+59.3%
0.15%
+27.3%
Q1 2017$6,255,000
+63.5%
99,500
+37.2%
0.12%
+37.5%
Q4 2016$3,826,000
-13.1%
72,500
-11.0%
0.09%
-17.0%
Q3 2016$4,402,000
+52.4%
81,500
+14.0%
0.11%
+41.3%
Q2 2016$2,889,000
-24.7%
71,500
-35.0%
0.08%
-21.9%
Q1 2016$3,839,000
-24.1%
110,000
-2.4%
0.10%
-28.9%
Q4 2015$5,058,000
+16.4%
112,7000.0%0.14%
+26.2%
Q3 2015$4,346,000
+99.5%
112,700
+150.4%
0.11%
+137.8%
Q2 2015$2,178,000
+36.9%
45,0000.0%0.04%
+40.6%
Q1 2015$1,591,000
-29.3%
45,000
-35.7%
0.03%
-31.9%
Q4 2014$2,249,00070,0000.05%
Other shareholders
SEATTLE GENETICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 57,170$10,013,0005.39%
Boxer Capital, LLC 400,000$70,056,0002.25%
PARTNERS CAPITAL INVESTMENT GROUP, LLP 110,153$19,292,0001.10%
DCF Advisers, LLC 13,300$2,329,0000.96%
XTX MARKETS LLC 2,418$423,0000.87%
FAIRFIELD, BUSH & CO. 15,035$2,633,0000.77%
Parcion Private Wealth LLC 4,520$792,0000.10%
Gulf International Bank (UK) Ltd 26,091$4,569,0000.06%
Princeton Portfolio Strategies Group LLC 1,500$263,0000.05%
Redpoint Investment Management Pty Ltd 2,392$419,0000.04%
View complete list of SEATTLE GENETICS INC shareholders